Delivery Order SPE2DB22D2103-SPE2DB23FR9BK

Award Date 5/11/23
Potential Completion Date 5/12/23
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,056.21, is a delivery order for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of March 26, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $26,458.84, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of April 8, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,519.46, is a firm fixed-price delivery order for ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The award has a ceiling value of $4,376.33 and an ultimate completion date of April 8, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication, with a ceiling value of $50,034.48. The contract is a firm fixed-price delivery order, with a period of performance through January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML. The contract has a ceiling value of $34,236.35 and a period of performance through March 11, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication, at a ceiling value of $12,601.23. The contract has a period of performance through July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML medication. The contract has a ceiling value of $21,427.19 and runs through January 15, 2025. It is a firm fixed-price contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,509.28, is a Delivery Order for the supply of ENBREL 50 MG/ML SURECLICKML pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $74,443.40, is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of January 17, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB23FR9BK
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication, with a ceiling value of $43,328.41 and a period of performance through May 12, 2023.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award did not utilize any set-aside designations, indicating open competition.

Generated 5/9/25, 10:15 AM